Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated just now
PreprintCC BY-NC-NDbioRxiv

HIV-1 envelope glycan loss links receptor adaptation and innate immune escape in SHIVs

  1. 1NC State University

Abstract

Simian-human immunodeficiency viruses (SHIVs) are widely used to model HIV-1 infection in macaques, yet most SHIVs encoding circulating HIV-1 envelope glycoproteins (Env) replicate poorly because of inefficient use of macaque CD4 and sensitivity to host antiviral responses. During adaptation to macaques, Env is therefore subject to multiple selective pressures to improve receptor utilization while maintaining function in the face of host immune restriction. Type I interferon (IFN) is a major component of the host antiviral response during acute infection, and IFN resistance increases during SHIV adaptation to macaques through serial passage. However, the viral determinants of this resistance have remained unclear. Here, we show that serial passage of a lineage of SHIVs in macaques selected Env variants with markedly increased resistance to IFN- and enhanced replication in macaque CD4+ T lymphocytes. IFN- resistance mapped principally to loss of two highly conserved N-linked glycans at N197 and N276 near the CD4-binding site. Glycan loss altered the conformational landscape of virus-associated Env, enhanced macaque CD4-dependent entry and membrane fusion without increasing human CD4-dependent entry, and reduced incorporation of the IFN-inducible restriction factors IFITM3 and IFITM3A into progeny virions. Depletion of IFITM3/3A rendered the parental SHIV highly resistant to IFN- and abolished differential IFN- sensitivity among parental, adapted, and glycan-loss viruses. These findings reveal that loss of receptor-proximal Env glycans can simultaneously improve utilization of a heterologous CD4 receptor and promote escape from IFN-mediated restriction, linking receptor adaptation and innate immune evasion during lentiviral adaptation to a new host.

Related

  1. Methadone Triggers Fetal Membrane Sterile Inflammation Through Innate Immune and Opioid Receptor Signaling
    M. E. Kelleher, H. M. Georges, L. C. Salmeron +3
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Microbial proteins shape the development of Fab-dimerized glycan-reactive antibodies that target glycosylated HIV-1 envelope
    Benae Clardy, Ryan Tuck, Kenneth Cronin +6
    iSciencePeer-reviewedCC BY-NC-ND 4.0ImmunologyMicrobiologyCell PressCrossref
  3. Humans and rhesus macaques share maturation pathways of HIV-1 envelope-reactive V3-glycan bnAb lineages
    Matthew Clark, Hui Joyce Li, Mitchell Martin +36
    Science Translational MedicinePeer-reviewedLicence not statedFull text5 citedMicrobiologyOpenAlex
  4. Host receptor networking and molecular mechanisms of innate immune evasion in hepatitis E virus pathogenesis
    Ali Zohaib, Maham Yamin, Muhammad Usama Butt +3
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textMicrobiologyCrossrefEurope PMCEurope PMCPMC
  5. Comparative Toll-like receptor profiling reveals breed-specific innate immune architecture following Newcastle disease vaccination.
    Patel Nikunjkumar, Gautham Kolluri, Abinaya Kaliappan +4
    Poultry sciencePeer-reviewedCC BYFull textImmunologyEurope PMC
BibTeX
@misc{smith2026hiv1,
  title = {{HIV-1 envelope glycan loss links receptor adaptation and innate immune escape in SHIVs}},
  author = {A. Smith and H. Weight and R. Katte and D. Kappala and A. Pimplapure and V. Mangala Prasad and M. Lu and J. Overbaugh and A. Sharma},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.12.758606},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.12.758606v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - HIV-1 envelope glycan loss links receptor adaptation and innate immune escape in SHIVs
AU  - A. Smith
AU  - H. Weight
AU  - R. Katte
AU  - D. Kappala
AU  - A. Pimplapure
AU  - V. Mangala Prasad
AU  - M. Lu
AU  - J. Overbaugh
AU  - A. Sharma
PY  - 2026
DA  - 2026/10/12
PB  - bioRxiv
DO  - 10.64898/2026.10.12.758606
UR  - https://www.biorxiv.org/content/10.64898/2026.10.12.758606v1
AB  - Simian-human immunodeficiency viruses (SHIVs) are widely used to model HIV-1 infection in macaques, yet most SHIVs encoding circulating HIV-1 envelope glycoproteins (Env) replicate poorly because of inefficient use of macaque CD4 and sensitivity to host antiviral responses. During adaptation to macaques, Env is therefore subject to multiple selective pressures to improve receptor utilization while maintaining function in the face of host immune restriction. Type I interferon (IFN) is a major component of the host antiviral response during acute infection, and IFN resistance increases during SHIV adaptation to macaques through serial passage. However, the viral determinants of this resistance have remained unclear. Here, we show that serial passage of a lineage of SHIVs in macaques selected Env variants with markedly increased resistance to IFN- and enhanced replication in macaque CD4+ T lymphocytes. IFN- resistance mapped principally to loss of two highly conserved N-linked glycans at N197 and N276 near the CD4-binding site. Glycan loss altered the conformational landscape of virus-associated Env, enhanced macaque CD4-dependent entry and membrane fusion without increasing human CD4-dependent entry, and reduced incorporation of the IFN-inducible restriction factors IFITM3 and IFITM3A into progeny virions. Depletion of IFITM3/3A rendered the parental SHIV highly resistant to IFN- and abolished differential IFN- sensitivity among parental, adapted, and glycan-loss viruses. These findings reveal that loss of receptor-proximal Env glycans can simultaneously improve utilization of a heterologous CD4 receptor and promote escape from IFN-mediated restriction, linking receptor adaptation and innate immune evasion during lentiviral adaptation to a new host.
ER  -